Stock Ratings / Health Care / IRTC / options

ICUI (56) NVST (46) PLSE (39) HTFL (53) ⌘ Pro Terminal →

iRhythm Holdings Inc. (IRTC) Options Positioning, Max Pain & Unusual Sweeps

$123.37 -3.47% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $122.37

iRhythm Holdings Inc. (IRTC) carries a Roarable Rating of D (Sell) with 47/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (47/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D • SELL / AVOID Cap $4.07B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on IRTC Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is IRTC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, iRhythm Holdings Inc. (NASDAQ: IRTC) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 47/100 at a spot price of $123.37 (-3.47% 1D, market cap $4.07B). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 9/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, IRTC ranks #298 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does IRTC compare to ICUI and NVST in the Health Care sector?

▼

Within the Health Care sector (Medical/Dental Instruments), IRTC carries a Roarable D (47/100 RQD), trailing P/E of N/A, gross margin of 70.6%, and ROIC of -13.5%. By comparison, ICUI (ICU Medical Inc.) holds a D+ grade (56/100 RQD, P/E N/A, ROIC 1.0%, cap $4.10B) and NVST (Envista Holdings Corporation) posts a D grade (46/100 RQD, P/E 84.1x, ROIC 5.1%, cap $3.78B). Among the 5-stock peer group, NVST leads on earnings multiple (84.1x) while NVST leads on capital efficiency (5.1% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for IRTC?

▼

Per IRTC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001388658), iRhythm Holdings Inc. generated $747.1M in revenue (+26.2% YoY), -$45.0M in net income, and $34.5M in free cash flow against $1.02B in total assets and $390.3M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $122.37 (-0.81%)🧬 Disciplined Float (+0.80% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 4.6% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (47/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.9% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for IRTC)Realized 20D OHLCV Swing Band: ±7.8%

Deterministic 5-Pillar Attribution (47/100 Composite)

🔍 WHY IRTC SCORES 47/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Cash Engine Quality+12/20 pts (26% of score)

SEC XBRL FY 2025 (10-K): 4.6% FCF Margin ($34.5M FCF) & 70.6% Gross Margin

▲ #2 Bullish Driver: Whale & Options Positioning+11/20 pts (23% of score)

20D Institutional Volume Accumulation (±7.8% realized swing band)

▼ #1 Drag / Risk Factor: Macro Regime Fit6/20 pts (-14 pt drag)

Macro rate sensitivity & RSI-14 (58.9) create a -14 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$106.05+7.1% Next Q

Q2 (-2Q)

Grade D$113.55+9.2% Next Q

Q3 (-1Q)

Grade D$123.99-0.5% Next Q

Current

Grade D$123.37-5.9% Hist 90D α

Trajectory: E (39) → D (47)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a IRTC Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While IRTC currently carries a cautious 47/100 (D) rating due to Macro Regime Fit (6/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($115.08) and Max Pain ($129.54) forces dealer call-delta covering toward $202.09.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.80% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $IRTC• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “IRTC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 47%NO 53%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±7.8%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (IRTC)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for IRTC.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring IRTC)

✓Walkthrough of IRTC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

IRTC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +3.52%📐 HORIZONTAL RANGE

2026-11-03O $127.8H $127.8L $123.4C $123.4VOL 533.5K

RES: $128.2SUP: $99.12SMA50: $115.1SMA200: $121.8

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

IRTC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 IRTC Butterfly Map → + Track IRTC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

23.1%/yr Implied 5Y Growth

vs. +26.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on IRTC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for IRTC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for IRTC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (IRTC)

Health Care Rank #298 of 1016 ⚔️ ICUI vs IRTC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (IRTC vs. ICUI, NVST, PLSE, HTFL)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, iRhythm Holdings Inc. (IRTC) ranks #298 by composite RQD confidence (47/100, grade D) and #178 by equity capitalization ($4.07B). Within this direct 5-issuer industry benchmark cohort, NVST leads on earnings valuation at 84.1x trailing P/E, while NVST leads on capital efficiency and profitability with 5.1% ROIC and 54.7% gross margin. ICUI currently holds the highest overall quantitative score in the immediate peer group at 56/100 (D+) compared with IRTC at 47/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
IRTC ACTIVE iRhythm Holdings Inc.	D	47/100	—	70.6%	-13.5%	-3.47%	$4.07B	Benchmark Subject
ICUI ICU Medical Inc.	D+	56/100	—	36.8%	1.0%	-2.89%	$4.10B	/icui-vs-irtc →
NVST Envista Holdings Corporation	D	46/100	84.1x	54.7%	5.1%	-4.47%	$3.78B	/nvst-vs-irtc →
PLSE Pulse Biosciences Inc	D-	39/100	—	-30.0%	-30.7%	-5.84%	$3.73B	/plse-vs-irtc →
HTFL Heartflow Inc.	D+	53/100	—	76.8%	-12.0%	-2.44%	$5.13B	/htfl-vs-irtc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001388658

In its most recent audited fiscal period (FY2025, filed 2025-12-31), iRhythm Holdings Inc. (IRTC) reported GAAP revenue of $747.1M (+26.2% vs. FY2024 revenue of $591.8M , and +51.6% cumulative change since FY2023) , GAAP net income of -$45.0M, operating cash flow of $80.9M, and free cash flow of $34.5M (+213.0% YoY). On the balance sheet, IRTC closed FY2025 with $1.02B in total assets against $390.3M in total debt (Altman Z-Score: 3.01, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$747.1M	-$45.0M	$80.9M	$34.5M	$1.02B	$390.3M
FY2024 (FY)	2024-12-31	$591.8M	-$113.0M	$3.4M	-$30.6M	$931.4M	$378.2M
FY2023 (FY)	2023-12-31	$492.7M	-$123.0M	-$50.1M	-$72.3M	$2.32B	$542.2M

3. IRTC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is IRTC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does IRTC compare to ICUI and NVST in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for IRTC?

Where is IRTC trading relative to its 50-day, 200-day, and 52-week technical levels?

IRTC last traded at $123.37 (-3.47% on volume of 533,468 shares), positioning the stock +7.20% above its 50-day simple moving average ($115.08) and +1.33% above its 200-day simple moving average ($121.75). Across its 52-week range of $100.70 to $192.47, IRTC sits at the 24.7% percentile with a 14-day RSI of 58.9 (BULLISH MOMENTUM) and an implied next-earnings move of ±7.8% ($113.75 to $132.99).

IRTC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is IRTC's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for IRTC.

Direct Sub-Reports: IRTC RQD Cockpit IRTC 12M Forecast IRTC Earnings & Move IRTC Dividends & DRIP IRTC Insiders & 13F IRTC Whale Options IRTC Profit Sankey IRTC News & Why

ROARABLE RATING BRIEF • RQD 47/100 (D) ✓ STAGE-C NUMBER FIREWALL VERIFIED

IRTC — iRhythm Holdings Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:22:02Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, IRTC scores 48 out of 100 with a letter grade of D, labeled "Roarable Sell — Underperform / Distribution Warning." The five pillars are:

Fundamental Cash Engine (12 / 20): Per the Roarable RQD rating, ROIC is -13.5% and FCF yield is 0.82%. Investor implication: the business is not currently generating returns above its cost of capital, and the cash yield on the current price is thin.
Whale 13F Flow (12 / 20): Per the Roarable RQD rating, this pillar reflects institutional accumulation and options positioning. Investor implication: institutional positioning is neutral-to-moderate rather than a strong tailwind.
Insider Conviction (9 / 20): Per the Roarable RQD rating, this pillar reflects SEC Form 4 and Congressional PTR cluster flow. Investor implication: insider and congressional activity does not provide strong conviction support.
Macro Regime Fit (6 / 20): Per the Roarable RQD rating, beta is 0.98 with sector sensitivity. Investor implication: the stock moves roughly in line with the market, and this pillar is the weakest, suggesting limited regime-based support.
Forensic Balance Sheet (9 / 20): Per the Roarable RQD rating, Altman Z is 3.01, Piotroski F is 7/9, and Debt/Equity is 2.38. Investor implication: the Altman Z reading and Piotroski score are relatively constructive, but leverage on a debt-to-equity basis is high.

Taken together, the pillar profile points to a business with a weak cash-return profile, high leverage relative to equity, and limited macro or insider tailwinds, offset partly by a respectable forensic score. Valuation tradeoffs are visible in the forward P/E of 30 against negative trailing EPS. Upside drivers would need to come from margin recovery and cash conversion; downside risk is elevated given the distribution-warning verdict.

Business

Per the profile, iRhythm Holdings Inc. is a NASDAQ-listed issuer in the Health Care sector, Medical/Dental Instruments industry. Per the SEC financials, FY 2025 revenue was $747.1M. Per the market data, gross margin is 70.6%. Not available in source data: a detailed description of products, customer segments, or revenue model.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$747.1M	$-57.4M	$-45.0M	N/A	$34.5M	$236.0M	$390.3M
FY 2024	$591.8M	$-115.5M	$-113.0M	N/A	$-30.6M	$419.6M	$378.2M
FY 2023	$492.7M	$-125.2M	$-123.0M	N/A	$-72.3M	N/A	$542.2M

Per the SEC financials, revenue grew from $492.7M (FY 2023) to $747.1M (FY 2025), while operating losses narrowed from $-125.2M to $-57.4M. Per the market data, operating margin is -7.7% and net margin is -6%. ROIC is -13.5% per the market data. Per the Roarable RQD rating, the Altman Z-Score is 3.01 and the Piotroski F-Score is 7/9, while Debt/Equity is 2.38. Cash declined from $419.6M to $236.0M over FY 2024 to FY 2025 while debt rose slightly from $378.2M to $390.3M.

Recent Catalysts & News Wire Analysis

Catalyst (green): Yahoo Finance reported on the stock as a possible bargain following a data breach probe.
Catalyst (green): TradingView reported that iRhythm completed the acquisition of VitalConnect for $237.5M and expects a revenue growth boost and a 15% adjusted EBITDA target for 2027.
Market wire (yellow): Seeking Alpha reported a new Overweight rating from Piper Sandler.
Market wire (yellow): Investing.com reported the stock hit a 52-week low at $100.70.
Market wire (yellow): GuruFocus reported a rise on the Piper Sandler Overweight rating and a $160 price target.
Risk watch (red): Yahoo Finance reported a modest fair value cut following VitalConnect and Zio MCT questions.

Per the Butterfly Supply-Chain Graph, supply chain is listed as NONE, with no butterfly links and no proprietary signals.

Open Questions

What is the trailing P/E and EV/EBITDA, which are marked unavailable in the source data?
What is the specific revenue and margin contribution expected from the VitalConnect acquisition, and when does the 15% adjusted EBITDA target apply?
What is the nature and scope of the data breach probe referenced in the news flow?
What are the terms and risk profile of the $390.3M debt, and what drove the decline in cash from $419.6M to $236.0M?
What drives the difference between the Piper Sandler $160 target and the current $127.8 price in the context of negative trailing EPS?

IRTC Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for iRhythm Holdings Inc. (IRTC) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to IRTC Debate Forum (3) ↓

🟢 CATALYST Yahoo Finance • 18h ago

iRhythm Holdings (IRTC) Stock May Be A Bargain After Data Breach Probe

Yahoo Finance report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Seeking Alpha • 21h ago

iRhythm stock a new Overweight at Piper Sandler (IRTC:NASDAQ)

Seeking Alpha report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Investing.com • 1d ago

iRhythm Holdings stock hits 52-week low at $100.70

Investing.com report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Yahoo Finance • 1d ago

iRhythm (IRTC) Stock Sees Modest Fair Value Cut After VitalConnect And Zio MCT Questions

Yahoo Finance report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST TradingView • 1d ago

iRhythm completes acquisition of VitalConnect for $237.5M, expects revenue growth boost and 15% adjusted EBITDA target for 2027

TradingView report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE GuruFocus • 1d ago

iRhythm Holdings (IRTC) Stock Rises on Piper Sandler Overweight Rating and $160 Price Target

GuruFocus report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 1d ago

A heart-monitoring platform can track up to 11 body signals. iRhythm bought VitalConnect.

Stock Titan report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE StockStory • 1d ago

2 Unprofitable Stocks with Competitive Advantages and 1 We Brush Off

StockStory report covering iRhythm Holdings Inc. (IRTC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

IRTC Bull vs. Bear Conversation Board — What's Your Call at $123.37?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON IRTC 🐻 50% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $138.02 (+8.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is IRTC (D • RQD 48/100) a Buy at $127.80?

Welcome to the IRTC (iRhythm Holdings Inc.) Roar Pit. Current RQD Composite is 48/100 (Roarable Sell — Underperform / Distribution Warning) in Medical/Dental Instruments. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

VA ValDiscipline Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $95.85 (-25.0%)

Spot @ $127.80

Pump the brakes on IRTC — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on IRTC, but look at what you are paying: current EV/EBITDA multiples with 70.6% gross margins. Unless iRhythm Holdings Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

CA CashFlowKing Verified K Arena Trader 🐂 BULLISH 🎯 Target: $150.80 (+18.0%)

Spot @ $127.80

IRTC cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on IRTC, the market is fixating on short-term headline noise in Medical/Dental Instruments and ignoring the balance sheet and cash flow trajectory. At $127.80 (52-wk range $100.70 - $192.47), any beat on forward guidance forces shorts and underweight funds to chase.